Management of Male Breast Cancer
Key Points
Key Points
In 2019, an estimated 2,670 new cases of breast cancer will be diagnosed among men in the United States, and about 500 men will die from breast cancer.
The lifetime risk of breast cancer is about 1:1000 for a man, whereas it is approximately 1:8 for a woman.
There are substantial knowledge gaps concerning the optimal management of breast cancer in men.
To date, approaches to treating men with breast cancer have been extrapolated largely from research conducted in women with breast cancer.
Treatment
...reatment
...with hormone receptor-positive breast cancer...
...ormone receptor-positive breast cancer who ar...
...treated with adjuvant endocrine therapy should...
...pleted five years of tamoxifen, have tolerated t...
...stage breast cancer should not be tre...
...ced or metastatic, hormone receptor-positive...
...p recurrent metastatic, hormone receptor-pos...
...docrine therapy for men with advanced or meta...
...rapy guided by HER2, PDL-1, PIK3CA, and germl...
...nagement of endocrine therapy toxicity i...
...ne/androgen supplementation should not be used by...
...hysicians should counsel patients a...
...lateral annual mammogram should be offered...
...ral annual mammogram may be offere...
...east MRI is not recommended routinely in me...
...th breast cancer should be offered ge...
Draft Recommendations That Did Not Reach the Requi...